Stay updated with breaking news from Mayo Collaborative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patent protection, regulatory exclusivity and product life cycle management should be at the core of any company’s life science development strategy. A well-integrated strategy will be...
Finnegan attorneys Paul Browning, Christopher Johns, Sara Leiman and Yelena Morozova explain some of the differences between patent-eligibility standards in the U.S. and those in other parts of the world.
To embed, copy and paste the code into your website or blog: C. R. Bard Inc. and Bard Peripheral Vascular, Inc. (collectively, Bard), and AngioDynamics, Inc., manufactured vascular access ports that were inserted under a patient’s skin to enable medical providers to insert fluid into the patient’s veins without having to initiate a new intravenous line. The Food and Drug Administration (FDA) warned medical providers not to use vascular access ports for power injection unless the ports were labeled for such use. 1 Bard sold vascular ports that could be used for power injection, even though...